Cel-Sci
CVM
#9791
Rank
$48.77 M
Marketcap
$5.80
Share price
-1.19%
Change (1 day)
-51.67%
Change (1 year)

Cel-Sci (CVM) - Total debt

Total debt on the balance sheet as of September 2025 : $9.38 Million USD

According to Cel-Sci 's latest financial reports the company's total debt is $9.38 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Cel-Sci - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2025-09-30$9.38 M-19.26%
2024-09-30$11.62 M-14.37%
2023-09-30$13.57 M-11.31%
2022-09-30$15.3 M-4.19%
2021-09-30$15.97 M14.6%
2020-09-30$13.93 M3.18%
2019-09-30$13.5 M0.96%
2018-09-30$13.37 M-5.82%
2017-09-30$14.2 M9.19%
2016-09-30$13.01 M-6.31%
2015-09-30$13.88 M1138.19%
2014-09-30$1.12 M-1.02%
2013-09-30$1.13 M2.64%
2012-09-30$1.1 M-77.91%
2011-09-30$4.99 M352.78%
2010-09-30$1.1 M-0.3%
2009-09-30$1.1 M453.67%
2008-09-30$0.2 M
2005-09-30$0 M0%
2004-09-30$0 M-99.66%
2003-09-30$0.87 M-50.78%
2002-09-30$1.77 M5583.6%
2001-09-30$0.03 M25.77%
2000-09-30$0.02 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
$45.79 B 487,916.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$54.58 B 581,609.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
$69.26 M 638.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
$1.96 M-79.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$17.07 B 181,839.28%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
$0.64 B 6,777.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
$0.66 B 6,966.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
$0.55 M-94.12%๐Ÿ‡บ๐Ÿ‡ธ USA